Article

Predictive Modeling of Alzheimer's and Parkinson's Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal Fluid

2022-01-24

Abstract excerpt

In recent years, metabolomics has been used as a powerful tool to better understand the physiology of neurodegenerative diseases and identify potential biomarkers for progression. We used targeted and untargeted aqueous, and lipidomic profiles of the metabolome from human cerebrospinal fluid to build multivariate predictive models distinguishing patients with Alzheimer’s disease (AD), Parkinson’s disea...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 011db154-db38-5b28-b780-df05aac0dafd
DOI: 10.20944/preprints202201.0357.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Predictive Modeling of Alzheimer's and Parkinson's Disease Using Metabolomic and Lipidomic Profiles from Cerebrospinal FluidDOI 10.20944/preprints202201.0357.v1Read

Metabolic profiling of CSF from people suffering from Sporadic and LRRK2 Parkinson’s disease: a pilot study.Semantic proximity Read

Serum metabolic signatures for Alzheimer’s Disease reveal alterations in amino acid composition: a validation studySemantic proximity Read

Metabolic Profiling of CSF from People Suffering from Sporadic and LRRK2 Parkinson's Disease: A Pilot Study.Semantic proximity Read

Cerebrospinal fluid and plasma metabolites in Parkinson's disease: a Mendelian randomization study.Semantic proximity Read

Sebum: a window into dysregulation of lipid metabolism in Parkinson’s diseaseSemantic proximity Read

Metabolomics of blood reveals age-dependent pathways in Parkinson’s DiseaseSemantic proximity Read

Cerebrospinal Fluid and Plasma Metabolites with Parkinson’s Disease: A Mendelian Randomization StudySemantic proximity Read

Differences in Plasma Metabolites Related to Alzheimer’s Disease, APOE-ε4 status and EthnicitySemantic proximity Read

Serum metabolic signatures for Alzheimer’s Disease reveal alterations in amino acid composition and energy metabolism – A validation studySemantic proximity Read

Multi-Omic Analysis Reveals Lipid Dysregulation Associated with Mitochondrial Dysfunction in Parkinson’s Disease BrainSemantic proximity Read

CSF metabolites associated with biomarkers of Alzheimer’s disease pathologySemantic proximity Read

Metabolomic Changes in Idiopathic and <i>GBA1</i> Parkinson’s DiseaseSemantic proximity Read